Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 9/20 | 0.67 |
| ▸ | NPC1 | O15118 | 5/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HPGDS | O60760 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL642784 | 0.89 | GCK (0.66) | GCKNPC1RAB9AKCNH2HPGDS | |
| SCHEMBL644145 | 0.88 | GCK (0.64) | GCKNPC1RAB9AKCNH2 | |
| SCHEMBL642186 | 0.86 | GCK (0.78) | GCKNPC1RAB9AKCNH2 | |
| SCHEMBL644232 | 0.85 | GCK (0.85) | GCKNPC1RAB9AKCNH2HPGDS | |
| SCHEMBL642638 | 0.85 | GCK (0.68) | GCKNPC1RAB9AKCNH2HPGDS | |
| SCHEMBL2663581 | 0.85 | GCK (0.65) | GCKNPC1RAB9AKCNH2HPGDS | |
| SCHEMBL642386 | 0.85 | GCK (0.65) | GCKNPC1RAB9AKCNH2 | |
| SCHEMBL642498 | 0.85 | GCK (0.72) | GCKNPC1RAB9AKCNH2 | |
| SCHEMBL644002 | 0.85 | GCK (0.65) | GCKNPC1RAB9AKCNH2HPGDS | |
| SCHEMBL642661 | 0.84 | GCK (0.68) | GCKNPC1RAB9AKCNH2HPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2463283-A1 | Fused phenyl Amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases | Pfizer Products Inc. (US) | 2012-06-13 | — | — | EP | disclosed |